PubMed:9973469
Annnotations
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-10 | protein | denotes | Fas ligand |
| T2 | 24-38 | cell_type | denotes | human NK cells |
| T3 | 71-98 | protein | denotes | calcineurin-nuclear factors |
| T4 | 138-148 | protein | denotes | Fas ligand |
| T5 | 150-154 | protein | denotes | FasL |
| T6 | 452-464 | protein | denotes | FasL protein |
| T7 | 469-473 | RNA | denotes | mRNA |
| T8 | 477-495 | cell_type | denotes | activated NK cells |
| T9 | 536-540 | protein | denotes | CD16 |
| T10 | 544-570 | cell_type | denotes | IL-2-preactivated NK cells |
| T11 | 649-653 | protein | denotes | FasL |
| T12 | 671-675 | protein | denotes | CD16 |
| T13 | 684-688 | protein | denotes | FasL |
| T14 | 902-906 | protein | denotes | FasL |
| T15 | 943-947 | protein | denotes | CD16 |
| T16 | 998-1002 | protein | denotes | FasL |
| T17 | 1016-1024 | cell_type | denotes | NK cells |
| T18 | 1065-1069 | protein | denotes | CD16 |
| T19 | 1104-1127 | protein | denotes | NF of activated T cells |
| T20 | 1129-1133 | protein | denotes | NFAT |
| T21 | 1184-1188 | protein | denotes | NFAT |
| T22 | 1332-1336 | protein | denotes | NFAT |
| T23 | 1495-1516 | protein | denotes | threonine phosphatase |
| T24 | 1532-1536 | protein | denotes | NFAT |
| T25 | 1591-1602 | protein | denotes | calcineurin |
| T26 | 1607-1611 | protein | denotes | NFAT |
| T27 | 1673-1677 | protein | denotes | FasL |
| T28 | 1691-1709 | cell_type | denotes | activated NK cells |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-137 | Sentence | denotes | Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway. |
| S2 | 138-266 | Sentence | denotes | Fas ligand (FasL) on cytotoxic lymphocytes is important for mediating apoptosis of activated lymphocytes and other target cells. |
| S3 | 267-416 | Sentence | denotes | We have reported that NK cell functions, such as proliferation, cell death, and killing activity, are subject to regulation by cellular redox status. |
| S4 | 417-523 | Sentence | denotes | Here, we report that expression of FasL protein and mRNA in activated NK cells is also regulated by redox. |
| S5 | 524-665 | Sentence | denotes | Ligation of CD16 on IL-2-preactivated NK cells resulted in reduction of intracellular peroxide level as well as induction of FasL expression. |
| S6 | 666-807 | Sentence | denotes | This CD16-induced FasL expression was suppressed by oxidative stress, including thiol deprivation or treatment with hydrogen peroxide (H2O2). |
| S7 | 808-918 | Sentence | denotes | Addition of thiol-reducing compounds, such as L-cystine, 2-ME, or N-acetyl cysteine, restored FasL expression. |
| S8 | 919-1025 | Sentence | denotes | These data suggest that CD16 stimulation requires cellular reducing status for FasL induction in NK cells. |
| S9 | 1026-1200 | Sentence | denotes | Because FasL gene activation following CD16 cross-linking is regulated by the NF of activated T cells (NFAT), we examined the effect of oxidative stresses on NFAT activation. |
| S10 | 1201-1412 | Sentence | denotes | Electrophoretic mobility shift assays revealed that both thiol insufficiency and H2O2 treatment suppressed DNA-binding activity of NFAT and that addition of thiol-reducing compounds reversed or even enhanced it. |
| S11 | 1413-1548 | Sentence | denotes | Furthermore, these oxidative stresses inhibited activity of calcineurin, a serine/threonine phosphatase that regulates NFAT activation. |
| S12 | 1549-1872 | Sentence | denotes | These results suggest that suppression of calcineurin and NFAT activation is a mechanism by which oxidative stress inhibits FasL induction in activated NK cells and further support the hypothesis that thiol-reducing compounds might be required for maintenance of optimal NK functions under physiologic oxidative conditions. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 24-38 | NP | denotes | human NK cells |
| C2 | 55-60 | NP | denotes | redox |
| C3 | 477-495 | NP | denotes | activated NK cells |
| C4 | 517-522 | NP | denotes | redox |
| C5 | 649-664 | NP | denotes | FasL expression |
| C6 | 718-734 | NP | denotes | oxidative stress |
| C7 | 767-806 | NP | denotes | treatment with hydrogen peroxide (H2O2) |
| C9 | 820-844 | NP | denotes | thiol-reducing compounds |
| C8 | 808-844 | NP | denotes | Addition of thiol-reducing compounds |
| C10 | 902-917 | NP | denotes | FasL expression |
| C11 | 1016-1024 | NP | denotes | NK cells |
| C12 | 1100-1134 | NP | denotes | the NF of activated T cells (NFAT) |
| C13 | 1162-1180 | NP | denotes | oxidative stresses |
| C14 | 1184-1199 | NP | denotes | NFAT activation |
| C15 | 1282-1296 | NP | denotes | H2O2 treatment |
| C17 | 1332-1336 | NP | denotes | NFAT |
| C16 | 1308-1336 | NP | denotes | DNA-binding activity of NFAT |
| C19 | 1358-1382 | NP | denotes | thiol-reducing compounds |
| C18 | 1346-1382 | NP | denotes | addition of thiol-reducing compounds |
| C20 | 1409-1411 | NP | denotes | it |
| C21 | 1426-1450 | NP | denotes | these oxidative stresses |
| C22 | 1473-1484 | NP | denotes | calcineurin |
| C24 | 1486-1516 | NP | denotes | a serine/threonine phosphatase |
| C25 | 1517-1521 | NP | denotes | that |
| C26 | 1532-1547 | NP | denotes | NFAT activation |
| C23 | 1486-1547 | NP | denotes | a serine/threonine phosphatase that regulates NFAT activation |
| C27 | 1591-1602 | NP | denotes | calcineurin |
| C28 | 1607-1622 | NP | denotes | NFAT activation |
| C29 | 1626-1637 | NP | denotes | a mechanism |
| C30 | 1641-1646 | NP | denotes | which |
| C31 | 1647-1663 | NP | denotes | oxidative stress |
| C32 | 1691-1709 | NP | denotes | activated NK cells |
| C33 | 1730-1744 | NP | denotes | the hypothesis |
| C34 | 1745-1749 | NP | denotes | that |
| C35 | 1750-1774 | NP | denotes | thiol-reducing compounds |
| R1 | C4 | C2 | coref-ident | redox,redox |
| R2 | C10 | C5 | coref-ident | FasL expression,FasL expression |
| R3 | C11 | C1 | coref-ident | NK cells,human NK cells |
| R4 | C15 | C7 | coref-ident | H2O2 treatment,treatment with hydrogen peroxide (H2O2) |
| R5 | C17 | C12 | coref-ident | NFAT,the NF of activated T cells (NFAT) |
| R6 | C19 | C9 | coref-ident | thiol-reducing compounds,thiol-reducing compounds |
| R7 | C18 | C8 | coref-ident | addition of thiol-reducing compounds,Addition of thiol-reducing compounds |
| R8 | C20 | C16 | coref-pron | it,DNA-binding activity of NFAT |
| R9 | C21 | C13 | coref-ident | these oxidative stresses,oxidative stresses |
| R10 | C25 | C24 | coref-relat | that,a serine/threonine phosphatase |
| R11 | C26 | C14 | coref-ident | NFAT activation,NFAT activation |
| R12 | C23 | C22 | coref-appos | a serine/threonine phosphatase that regulates NFAT activation,calcineurin |
| R13 | C27 | C22 | coref-ident | calcineurin,calcineurin |
| R14 | C28 | C26 | coref-ident | NFAT activation,NFAT activation |
| R15 | C30 | C29 | coref-relat | which,a mechanism |
| R16 | C31 | C6 | coref-ident | oxidative stress,oxidative stress |
| R17 | C32 | C3 | coref-ident | activated NK cells,activated NK cells |
| R18 | C34 | C33 | coref-relat | that,the hypothesis |
| R19 | C35 | C19 | coref-ident | thiol-reducing compounds,thiol-reducing compounds |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-10 | protein_molecule | denotes | Fas ligand |
| T2 | 24-38 | cell_type | denotes | human NK cells |
| T3 | 71-98 | protein_family_or_group | denotes | calcineurin-nuclear factors |
| T4 | 138-148 | protein_molecule | denotes | Fas ligand |
| T5 | 150-154 | protein_molecule | denotes | FasL |
| T6 | 438-448 | other_name | denotes | expression |
| T7 | 452-464 | protein_molecule | denotes | FasL protein |
| T8 | 469-473 | RNA_molecule | denotes | mRNA |
| T9 | 477-495 | cell_type | denotes | activated NK cells |
| T10 | 536-540 | protein_molecule | denotes | CD16 |
| T11 | 544-549 | cell_type | denotes | IL-2- |
| T12 | 549-570 | cell_type | denotes | preactivated NK cells |
| T13 | 596-624 | other_name | denotes | intracellular peroxide level |
| T14 | 649-653 | protein_molecule | denotes | FasL |
| T15 | 671-675 | protein_molecule | denotes | CD16 |
| T16 | 684-688 | protein_molecule | denotes | FasL |
| T17 | 718-734 | other_name | denotes | oxidative stress |
| T18 | 746-763 | other_name | denotes | thiol deprivation |
| T19 | 782-799 | inorganic | denotes | hydrogen peroxide |
| T20 | 801-805 | inorganic | denotes | H2O2 |
| T21 | 854-863 | amino_acid_monomer | denotes | L-cystine |
| T22 | 865-869 | amino_acid_monomer | denotes | 2-ME |
| T23 | 874-891 | amino_acid_monomer | denotes | N-acetyl cysteine |
| T24 | 902-906 | protein_molecule | denotes | FasL |
| T25 | 943-947 | protein_molecule | denotes | CD16 |
| T26 | 998-1002 | protein_molecule | denotes | FasL |
| T27 | 1016-1024 | cell_type | denotes | NK cells |
| T28 | 1065-1069 | protein_molecule | denotes | CD16 |
| T29 | 1104-1119 | protein_molecule | denotes | NF of activated |
| T30 | 1120-1127 | cell_type | denotes | T cells |
| T31 | 1129-1133 | protein_molecule | denotes | NFAT |
| T32 | 1162-1180 | other_name | denotes | oxidative stresses |
| T33 | 1184-1188 | protein_family_or_group | denotes | NFAT |
| T34 | 1201-1238 | other_name | denotes | Electrophoretic mobility shift assays |
| T35 | 1282-1286 | inorganic | denotes | H2O2 |
| T36 | 1308-1328 | other_name | denotes | DNA-binding activity |
| T37 | 1332-1336 | protein_family_or_group | denotes | NFAT |
| T38 | 1358-1382 | other_organic_compound | denotes | thiol-reducing compounds |
| T39 | 1432-1450 | other_name | denotes | oxidative stresses |
| T40 | 1488-1494 | amino_acid_monomer | denotes | serine |
| T41 | 1495-1504 | amino_acid_monomer | denotes | threonine |
| T42 | 1532-1536 | protein_family_or_group | denotes | NFAT |
| T43 | 1591-1602 | protein_molecule | denotes | calcineurin |
| T44 | 1607-1611 | protein_family_or_group | denotes | NFAT |
| T45 | 1647-1663 | other_name | denotes | oxidative stress |
| T46 | 1673-1677 | protein_molecule | denotes | FasL |
| T47 | 1691-1700 | cell_type | denotes | activated |
| T48 | 1701-1709 | cell_type | denotes | NK cells |
| T49 | 1750-1774 | other_organic_compound | denotes | thiol-reducing compounds |
| T50 | 1820-1832 | other_name | denotes | NK functions |
| T51 | 1839-1871 | other_name | denotes | physiologic oxidative conditions |